The monthly trends of malaria cases in children under 5 years of age in Guinea: comparative analysis between a seasonal malaria chemoprevention (SMC) and a non-SMC health district.
Children under 5
Effect
Guinea
Malaria
Monthly trends
Seasonal Malaria Chemoprevention
Journal
Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802
Informations de publication
Date de publication:
08 Aug 2024
08 Aug 2024
Historique:
received:
13
04
2024
accepted:
27
07
2024
medline:
9
8
2024
pubmed:
9
8
2024
entrez:
8
8
2024
Statut:
epublish
Résumé
The Republic of Guinea, where malaria represents the leading cause of morbidity and mortality among children, the seasonal malaria chemoprevention (SMC) is deployed only in areas with very seasonal modes of transmission. It should target children at the highest risk of serious illness. The objective of the study was to prevent uncomplicated and serious cases of malaria in the target population. This study aimed to analyse the monthly trends in malaria-related morbidity among children under the age of 5 in Guinea. This was a quasi-experimental study with routine data from the National Health Information System (SNIS). The two districts Mamou (the SMC intervention site) and Kindia (the control site) were selected to compare the monthly trends in malaria cases among children under the age of 5, from July to October, covering the years from 2015 to 2020. The statistical analysis used interrupted time series to estimate the effects of the SMC. The SMC programme contributed to a significant average reduction in the number of malaria cases of 225 cases per month in the intervention district (95% CI - 362 to - 88; p = 0.002), compared to the control district. However, the study also revealed that the effect of SMC varied between cycles, presenting different monthly malaria cases. The SMC contributed to a significant reduction in malaria cases among children under the age of 5 in the health district of Mamou from 2018 to 2020. However, this reduction varied by monthly SMC cycle. This study suggests extending the SMC in other areas with high perennial seasonal transmission respecting the World Health Organization SMC eligibility criteria, as a strategy in the dynamic of reducing malaria cases in children under the age of 5 in Guinea.
Sections du résumé
BACKGROUND
BACKGROUND
The Republic of Guinea, where malaria represents the leading cause of morbidity and mortality among children, the seasonal malaria chemoprevention (SMC) is deployed only in areas with very seasonal modes of transmission. It should target children at the highest risk of serious illness. The objective of the study was to prevent uncomplicated and serious cases of malaria in the target population. This study aimed to analyse the monthly trends in malaria-related morbidity among children under the age of 5 in Guinea.
METHODS
METHODS
This was a quasi-experimental study with routine data from the National Health Information System (SNIS). The two districts Mamou (the SMC intervention site) and Kindia (the control site) were selected to compare the monthly trends in malaria cases among children under the age of 5, from July to October, covering the years from 2015 to 2020. The statistical analysis used interrupted time series to estimate the effects of the SMC.
RESULTS
RESULTS
The SMC programme contributed to a significant average reduction in the number of malaria cases of 225 cases per month in the intervention district (95% CI - 362 to - 88; p = 0.002), compared to the control district. However, the study also revealed that the effect of SMC varied between cycles, presenting different monthly malaria cases.
CONCLUSION
CONCLUSIONS
The SMC contributed to a significant reduction in malaria cases among children under the age of 5 in the health district of Mamou from 2018 to 2020. However, this reduction varied by monthly SMC cycle. This study suggests extending the SMC in other areas with high perennial seasonal transmission respecting the World Health Organization SMC eligibility criteria, as a strategy in the dynamic of reducing malaria cases in children under the age of 5 in Guinea.
Identifiants
pubmed: 39118160
doi: 10.1186/s12936-024-05060-4
pii: 10.1186/s12936-024-05060-4
doi:
Substances chimiques
Antimalarials
0
Types de publication
Journal Article
Comparative Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
237Informations de copyright
© 2024. The Author(s).
Références
WHO. World malaria report 2023: 23 years of global progress and challenges. Geneva, World Health Organization, 2023, Available: https://www.who.int/publications/i/item/9789240086173 .
Ansah PO, Ansah NA, Malm K, Awuni D, Peprah N, Dassah S, et al. Evaluation of pilot implementation of seasonal malaria chemoprevention on morbidity in young children in Northern Sahelian Ghana. Malar J. 2021;20:440.
doi: 10.1186/s12936-021-03974-x
pubmed: 34794431
pmcid: 8600740
WHO. Seasonal malaria chemoprevention with sulfadoxine–pyrimethamine plus amodiaquine in children: a field guide. Geneva: World Health Organization; 2023.
WHO. Seasonal malaria chemoprevention with sulfadoxine–pyrimethamine plus amodiaquine in children: a field guide. Geneva: World Health Organization; 2013.
Meremikwu MM, Donegan S, Sinclair D, Esu E, Oringanje C. Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. Cochrane Database Syst Rev. 2012;2012:CD003756.
pubmed: 22336792
pmcid: 6532713
Cairns M, Roca-Feltrer A, Garske T, Wilson AL, Diallo D, Milligan PJ, et al. Estimating the potential public health impact of seasonal malaria chemoprevention in African children. Nat Commun. 2012;3:881.
doi: 10.1038/ncomms1879
pubmed: 22673908
Traore A, Donovan L, Sawadogo B, Ward C, Smith H, Rassi C, et al. Extending seasonal malaria chemoprevention to five cycles: a pilot study of feasibility and acceptability in Mangodara district, Burkina Faso. BMC Public Health. 2022;22:442.
doi: 10.1186/s12889-022-12741-9
pubmed: 35247990
pmcid: 8897918
Coldiron ME, Von Seidlein L, Grais RF. Seasonal malaria chemoprevention: successes and missed opportunities. Malar J. 2017;16:481.
doi: 10.1186/s12936-017-2132-1
pubmed: 29183327
pmcid: 5704360
Bisanzio D, Keita MS, Camara A, Guilavogui T, Diallo T, Barry H, et al. Malaria trends in districts that were targeted and not-targeted for seasonal malaria chemoprevention in children under 5 years of age in Guinea, 2014–2021. BMJ Glob Health. 2024;9: e013898.
doi: 10.1136/bmjgh-2023-013898
pubmed: 38413098
pmcid: 10900330
Ministry of Health. Annual Bulletin of the National Guinea Malaria Profile 2022. Available: https://d1u4sg1s9ptc4z.cloudfront.net/uploads/2023/01/Guinea-Malaria-Profile-1 .
Beavogui AH, Delamou A, Camara BS, Camara D, Kourouma K, Camara R, et al. Prevalence of malaria and factors associated with infection in children aged 6 months to 9 years in Guinea: results from a national cross-sectional study. Parasite Epidemiol Control. 2020;11: e00162.
doi: 10.1016/j.parepi.2020.e00162
pubmed: 32715113
pmcid: 7378695
Sayre D, Camara A, Barry Y, Deen TB, Camara D, Dioubaté M, et al. Combined epidemiologic and entomologic survey to detect urban malaria transmission, Guinea, 2018. Emerg Infect Dis. 2021;27:599–602.
doi: 10.3201/eid2702.191701
pubmed: 33496219
pmcid: 7853535
Lama DEN. Direction Nationale de la Statistique (DNS) [Guinée]. 2017. Annuaire statistique sanitaire.
Bernal JL, Cummins S, Gasparrini A. The use of controls in interrupted time series studies of public health interventions. Int J Epidemiol. 2018;47:2082–93.
doi: 10.1093/ije/dyy135
Singh MP, Rajvanshi H, Bharti PK, Anvikar AR, Lal AA. Time series analysis of malaria cases to assess the impact of various interventions over the last three decades and forecasting malaria in India towards the 2030 elimination goals. Malar J. 2024;23:50.
doi: 10.1186/s12936-024-04872-8
pubmed: 38360708
pmcid: 10870538
Delamou A, Ayadi AME, Sidibe S, Delvaux T, Camara BS, Sandouno SD, et al. Effect of Ebola virus disease on maternal and child health services in Guinea: a retrospective observational cohort study. Lancet Glob Health. 2017;5:e448–57.
doi: 10.1016/S2214-109X(17)30078-5
pubmed: 28237252
pmcid: 6530984
Lagarde M. How to do (or not to do) … Assessing the impact of a policy change with routine longitudinal data. Health Policy Plan. 2012;27:76–83.
doi: 10.1093/heapol/czr004
pubmed: 21278077
Cairns M, Ceesay SJ, Sagara I, Zongo I, Kessely H, Gamougam K, et al. Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case–control studies in 5 countries. PLoS Med. 2021;18: e1003727.
doi: 10.1371/journal.pmed.1003727
pubmed: 34495978
pmcid: 8457484
Oumar AA. Impact of malaria prevention chemotherapy on morbidity and mortality in children 3–59 months of age in the Health District of Diré Mali. Health Sci Dis. 2021;22:39–42.
Richardson S, Moukenet A, Diar MSI, De Cola MA, Rassi C, Counihan H, et al. Modeled impact of seasonal malaria chemoprevention on district-level suspected and confirmed malaria cases in Chad based on routine clinical data (2013–2018). Am J Trop Med Hyg. 2021;105:1712–21.
doi: 10.4269/ajtmh.21-0314
pubmed: 34662864
pmcid: 8641328
Ambe JP, Balogun ST, Waziri MB, Nglass IN, Saddiq A. Impacts of seasonal malaria chemoprevention on malaria burden among under five-year-old children in Borno State. Nigeria J Trop Med. 2020;2020:9372457.
pubmed: 32665781
De Cola MA, Sawadogo B, Richardson S, Ibinaiye T, Traoré A, Compaoré CS, et al. Impact of seasonal malaria chemoprevention on prevalence of malaria infection in malaria indicator surveys in Burkina Faso and Nigeria. BMJ Glob Health. 2022;7: e008021.
doi: 10.1136/bmjgh-2021-008021
pubmed: 35589153
pmcid: 9121431
Kirakoya-Samadoulougou F, De Brouwere V, Fokam AF, Ouédraogo M, Yé Y. Assessing the effect of seasonal malaria chemoprevention on malaria burden among children under 5 years in Burkina Faso. Malar J. 2022;21:143.
doi: 10.1186/s12936-022-04172-z
pubmed: 35524310
pmcid: 9074217
Baba E, Hamade P, Kivumbi H, Marasciulo M, Maxwell K, Moroso D, et al. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study. Lancet. 2020;396:1829–40.
doi: 10.1016/S0140-6736(20)32227-3
Diawara F, Steinhardt LC, Mahamar A, Traore T, Kone DT, Diawara H, et al. Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali. Malar J. 2017;16:325.
doi: 10.1186/s12936-017-1974-x
pubmed: 28797263
pmcid: 5553795
Druetz T, Corneau-Tremblay N, Millogo T, Kouanda S, Ly A, Bicaba A, et al. Impact evaluation of seasonal malaria chemoprevention under routine program implementation: a auasi-experimental study in Burkina Faso. Am J Trop Med Hyg. 2018;98:524–33.
doi: 10.4269/ajtmh.17-0599
pubmed: 29260654
Cairns ME, Sagara I, Zongo I, Kuepfer I, Thera I, Nikiema F, et al. Evaluation of seasonal malaria chemoprevention in two areas of intense seasonal malaria transmission: Secondary analysis of a household-randomised, placebo-controlled trial in Houndé District, Burkina Faso and Bougouni District, Mali. PLoS Med. 2020;17: e1003214.
doi: 10.1371/journal.pmed.1003214
pubmed: 32822362
pmcid: 7442230
Khan J, Suau Sans M, Okot F, Rom Ayuiel A, Magoola J, Rassi C, et al. A quasi-experimental study to estimate effectiveness of seasonal malaria chemoprevention in Aweil South County in Northern Bahr El Ghazal. South Sudan Malar J. 2024;23:33.
pubmed: 38267985